Effect of Oxelidine on early postoperative pain and quality of recovery in patients undergoing thoracoscopic pneumonectomy: a randomized double-blind controlled trial

Tianjin Cancer Hospital Airport Hospital

lung cancer

Preention Study

Post-market

Clinical research on the integrated diagnosis and treatment of lung cancer based on targeted FAP

The First Affiliated Hospital of Guangzhou Medical University

Therapy Study

Premarket

Prospective, randomized, controlled phase II clinical study of LDRT+SBRT to reverse resistance to first-line PD(L)-1 monoclonal antibody combination therapy in driver-negative stage IV non-small cell lung cancer

Hubei cancer hospital

Non-small cell lung cancer

Therapy Study

A Phase I clinical study to evaluate the safety and feasibility of αPD-L1/4-1BB modification with targeted DLL3 CAR-T cells in patients with relapsed or refractory small cell lung cancer (SCLC)

West China Hospital, Sichuan University

Extensive-stage Small Cell Lung Cancer

Therapy Study

Premarket

Construction of a Prediction Model for Postoperative Pulmonary Complications in Lung Cancer Patients Based on Evidence-Based Medicine

Affiliated Hospital of Zunyi Medical University

Lung complications after lung cancer surgery

Preention Study

Premarket

Phrenic nerve compression for the treatment of pleural residual cavity and lung leakage after pneumonectomy---A prospective, randomized, controlled trial study.

The Affiliated Hospital of Inner Mongolia Medical University

lung cancer

Preention Study

Premarket

A single-center, single-arm, phase II prospective study to evaluate the efficacy and safety of PD-L1 inhibitors in the treatment of advanced non-small-cell lung carcinoma resistant or intolerant to PD-1 inhibitors

advanced non-small-cell lung carcinoma

Therapy Study

Post-market

clinical practice of PET-guided adaptive chemoradiotherapy on lung cancers

West China Hospital

lung cancer

Diagnostic Accuracy Test

Premarket

A prospective, multicenter, non-interventional, real-world study to characterize changes in molecular markers after three weeks of targeted therapy with oxitinib in Chinese patients with stage IV metastatic or recurrent non-squamous EGFR-positive NSCLC

non-small cell lung cancer

Cause Study

Post-market

Post-transcriptional regulation of KLF15 by DsrNA-binding protein Stau1 is observed Mechanism of progression in non-small cell lung cancer

People's Hospital of Xinjiang Uygur Autonomous Region

lung cancer

Cause Study